EOS imaging announces new installation in a top-ranking speciality orthopaedic hospital in China

Beijing Jishuitan Hospital adopts the EOS low dose, 2D/3D orthopaedic imaging system

EOS imaging, a company specialising in 2D and 3D imaging and data solutions for orthopaedics, has announced the installation of an EOS system at the Beijing Jishuitan Hospital, a top-ranking speciality orthopaedic hospital in China.

This installation follows the first two installations of EOS systems in China last year. The Beijing Jishuitan Hospital is a large-scale, first-level hospital that focuses on orthopaedics through its Beijing Bone and Arthropathy Researching Centre, Post-Operative Total Joint Arthroplasty Evaluation Centre, and   Orthopaedics Training Centre.

The hospital has approximately 1,000 beds, 200 doctors, and 2,200 full-time staff members. In 2016, Beijing Jishuitan Hospital performed more than 40,000 orthopaedic surgeries, making it the first specialty orthopaedic institution worldwide in terms of surgical volumes.

Xiaoguang Cheng, (Radiology Department, Beijing Jishuitan Hospital, Beijing, China), Committee and Vice Chief Secretary of the Chinese Association of Radiologists, comments, “As the head of the Radiology Department at Beijing Jishuitan Hospital, patient safety and diagnostic quality are very important to me, which is why I’m looking forward to providing the lowest dose imaging system to our patients and the valuable 2D/3D images and data to our surgeons. EOS is the optimal choice to satisfy our demands for safe imaging and sustainable long term positive outcomes, and I am sure our patients will now have a better experience here.”

Marie Meynadier, Chief Executive Officer of EOS imaging, says, “Following the first Chinese installations in Shanghai and the Jiangsu Province in 2017, we are pleased with the continued growth in the country, championed by leading physicians and prestigious institutions such as Jishuitan. The Chinese market includes more than 1,200 top grade hospitals, and we look forward to providing our technology to the patients they treat.”

EOS imaging is authorised to market in 51 countries, including the US, Japan and in the European Union.


Please enter your comment!
Please enter your name here